>There's been at least one human study that looked at Clioquinol in the
>treatment of AD (Arch. Neurol. 2003;60:1685-1691). It was a phase 2
[quoted text clipped - 7 lines]
>to a risk of B12 deficiency and something called subactute myelo-optic
>neuropathy.
Thanks Darryl,
Interesting, would like to know how the dose is arrived at,
solubility/persistence in spinal fluid, toxicity limits,
invasive tests of distribution/flow - opinions ?
>>Anyone here from Australia see the item on ABC (Channel 2)
>>on Catalyst a few weeks back ?
>
>Nope. I AM Canadian :-)
Must be a cultural joke/thing, over here ABC is "Australian
Broadcasting Corporation" government funded, nothing to
do with ABC in USA, Channel 2 is the analog channel,
as is 2 in SD digital but HD is 20, which doesnt have
much content. My agent is from Canada, Vancouver :-)
Basic item was some Australian researches came up with
old antibiotic Clioquinol to 'handle' the copper and zinc found at
amyloid deposits, repeated again on a comemrcial station
just yesterday. My 71 yr old mom had her first CT scan
today, not sure yet of clinical diagnosis but AD is a
first candidate unfortunately.
Rgds
Mike,
Perth, Western Australia
>Darryl.